Document is current
Any future updates will be listed below
-
Authors
Xu, Kevin Y. https://orcid.org/0000-0001-6595-695X
Berkel, Tiffani D. M.
Martin, Caitlin E. https://orcid.org/0000-0001-5560-458X
Jones, Hendrée E.
Carter, Ebony B.
Kelly, Jeannie C.
Mintz, Carrie M.
Levin, Frances R.
Grucza, Richard A.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (T32 DA015035, K12 K12DA041449, APA Psychiatric Research Fellowship, K23 DA053507, R21 DA044744)
- License Information
-
More Information
Article History
Received: 9 August 2023
Accepted: 16 May 2024
First Online: 11 June 2024
Competing interests
: R.A.G. reported receiving grants from the NIH and Arnold Ventures LLC during the conduct of the study, consulting for Janssen Pharmaceuticals and receiving personal fees for grant reviews from the NIH outside the submitted work. These funding sources had no influence on the design and analysis of the present study. The remaining authors declare no competing interests.
